ATE506371T1 - C-glycosylisoflavone mit alkylaminoalkoxylsubstituent, deren herstellung und deren verwendung - Google Patents

C-glycosylisoflavone mit alkylaminoalkoxylsubstituent, deren herstellung und deren verwendung

Info

Publication number
ATE506371T1
ATE506371T1 AT04738326T AT04738326T ATE506371T1 AT E506371 T1 ATE506371 T1 AT E506371T1 AT 04738326 T AT04738326 T AT 04738326T AT 04738326 T AT04738326 T AT 04738326T AT E506371 T1 ATE506371 T1 AT E506371T1
Authority
AT
Austria
Prior art keywords
treatment
glycosylisoflavones
alkylaminoalkoxyl
substituent
prevention
Prior art date
Application number
AT04738326T
Other languages
English (en)
Inventor
Lin Wang
Qiujun Lu
Shangri Wang
Tao Peng
Xiaowei Zhu
Shouguo Zhang
Jianping Ren
Lu Li
Ling Han
Yiguang Jin
Fengsheng Che
Original Assignee
Inst Radiation Med Amms Pla
Hainan Yangpu New & Special Medicine Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Radiation Med Amms Pla, Hainan Yangpu New & Special Medicine Co Ltd filed Critical Inst Radiation Med Amms Pla
Application granted granted Critical
Publication of ATE506371T1 publication Critical patent/ATE506371T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06Benzopyran radicals
    • C07H17/065Benzo[b]pyrans
    • C07H17/07Benzo[b]pyran-4-ones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
AT04738326T 2003-07-03 2004-07-02 C-glycosylisoflavone mit alkylaminoalkoxylsubstituent, deren herstellung und deren verwendung ATE506371T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNA031485472A CN1566128A (zh) 2003-07-03 2003-07-03 含烷胺基烷氧基取代的糖碳甙异黄酮化合物及其制法和用途
PCT/CN2004/000728 WO2005003146A1 (fr) 2003-07-03 2004-07-02 C-glycosylisoflavones a substituant alkylaminoalcoxyle, leur preparation et leur utilisation

Publications (1)

Publication Number Publication Date
ATE506371T1 true ATE506371T1 (de) 2011-05-15

Family

ID=33557750

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04738326T ATE506371T1 (de) 2003-07-03 2004-07-02 C-glycosylisoflavone mit alkylaminoalkoxylsubstituent, deren herstellung und deren verwendung

Country Status (6)

Country Link
US (1) US7727965B2 (de)
EP (1) EP1647555B1 (de)
CN (2) CN1566128A (de)
AT (1) ATE506371T1 (de)
DE (1) DE602004032346D1 (de)
WO (1) WO2005003146A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8436155B2 (en) * 2010-04-29 2013-05-07 Shandong University 7,2″-dehydrate puerarin and its salts, preparation method and use thereof
CN102443027B (zh) * 2010-10-13 2014-10-29 南京工业大学 果糖基化葛根素及其制备方法与用途
CN103044409A (zh) * 2012-12-05 2013-04-17 东南大学 葛根素衍生物或其药学上可接受的盐及其应用
CN103694229B (zh) * 2013-12-31 2016-03-23 深圳市健元医药科技有限公司 葛根素衍生物及其制备方法
CN104447718A (zh) * 2014-10-10 2015-03-25 泸州医学院 葛根素磺酸钠的制备及其用途
CN107003604B (zh) * 2014-10-15 2020-08-11 奇美实业股份有限公司 感光性树脂组成物、彩色滤光片的制造方法、彩色滤光片以及液晶显示装置
CN107098893A (zh) * 2017-05-31 2017-08-29 陕西中医药大学 一种葛根素衍生物及其制备方法和应用
CN110075067B (zh) * 2018-07-02 2021-03-23 中国人民解放军军事科学院军事医学研究院 一种盐酸葡酮胺微乳制剂及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ537366A (en) 2002-06-27 2007-12-21 Endowment For Res In Human Bio Compounds useful for the inhibition of ALDH
CN1186026C (zh) * 2002-08-09 2005-01-26 陕西镇坪制药厂 羟乙葛根素在制备治疗缺血性脑血管病新药中的应用

Also Published As

Publication number Publication date
EP1647555B1 (de) 2011-04-20
DE602004032346D1 (de) 2011-06-01
CN1566128A (zh) 2005-01-19
CN100480253C (zh) 2009-04-22
EP1647555A4 (de) 2007-02-21
US7727965B2 (en) 2010-06-01
US20080293642A1 (en) 2008-11-27
WO2005003146A1 (fr) 2005-01-13
EP1647555A1 (de) 2006-04-19
CN1809581A (zh) 2006-07-26

Similar Documents

Publication Publication Date Title
DE50309979D1 (de) Neue purinderivate, deren herstelllung und deren verwendung als arzneimittel
CA2474578A1 (en) Novel pyridin- and pyrimidin-derivatives
ATE469161T1 (de) Pyrazolderivat, dieses enthaltende medizinische zusammensetzung, medizinische verwendung davon, und zwischenprodukt für dessen herstellung
ATE526331T1 (de) Pyrrolopyrimidine für pharmazeutische zusammensetzungen
NO20085067L (no) 4,5-difenyl-pyrimidinyl substituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20080789L (no) 1,4-benzotiazepin 1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende denne forbindelsen og anvendelse derav som et hypolipid
NO20055680L (no) Heksahydropyridoisokinoliner som DPP-IV-inhibitorer
WO2008055870A8 (en) Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture
WO2007082808A3 (en) Thiazoles as 11 beta-hsd1 inhibitors
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
WO2006099943A8 (de) Amid substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NO20085066L (no) 4,5-difenyl-pyrimidinyl-aminosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20072389L (no) Substituerte benzokinolizinderivater
TW200505919A (en) DPP-IV inhibitors
ATE524469T1 (de) Alkinylarylverbindungen und salze davon, diese enthaltende pharmazeutische zusammensetzungen, verfahren zu deren herstellung und deren verwendungen
DE50106698D1 (de) Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
WO2006026204A3 (en) Novel gamma-lactams as beta-secretase inhibitors
DE50310161D1 (de) Kationisch substituierte diphenylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
IL176914A0 (en) Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
IL172290A0 (en) Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain
IL176915A0 (en) Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
WO2009057974A3 (en) Novel 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation
ATE506371T1 (de) C-glycosylisoflavone mit alkylaminoalkoxylsubstituent, deren herstellung und deren verwendung
ATE454383T1 (de) Neue verbindungen, deren verwendung und herstellung
HK1077070A1 (en) Oligosaccharide derivative

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties